1,2-dimethylhydrazine increases expression ISO RGD:1620902 6480464 1, 2-Dimethylhydrazine results in increased expression of FOXC1 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:1353830 6480464 Estradiol results in increased expression of FOXC1 mRNA CTD PMID:16029874 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1620902 6480464 Tetrachlorodibenzodioxin results in decreased expression of FOXC1 mRNA CTD PMID:18691609 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FOXC1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FOXC1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1620902 6480464 Tetrachlorodibenzodioxin results in increased expression of FOXC1 mRNA CTD PMID:24058054 2-methylcholine affects expression ISO RGD:1353830 6480464 beta-methylcholine affects the expression of FOXC1 mRNA CTD PMID:21179406 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of FOXC1 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol increases expression ISO RGD:1620902 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FOXC1 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1353830 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of FOXC1 mRNA CTD PMID:17891453 5-fluorouracil affects expression ISO RGD:1353830 6480464 Fluorouracil affects the expression of FOXC1 mRNA CTD PMID:16584549 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FOXC1 mRNA CTD PMID:24780913 , PMID:30047161 all-trans-retinoic acid increases expression ISO RGD:1353830 6480464 Tretinoin results in increased expression of FOXC1 mRNA CTD PMID:17431108 more ... all-trans-retinoic acid affects expression ISO RGD:1353830 6480464 Tretinoin affects the expression of FOXC1 mRNA CTD PMID:31600526 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of FOXC1 mRNA CTD PMID:30047161 antirheumatic drug decreases expression ISO RGD:1353830 6480464 Antirheumatic Agents results in decreased expression of FOXC1 mRNA CTD PMID:24449571 atrazine multiple interactions ISO RGD:1353830 6480464 [Atrazine co-treated with Arsenates] results in increased expression of FOXC1 mRNA CTD PMID:18585445 benzalkonium chloride multiple interactions ISO RGD:1620902 6480464 [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of FOXC1 mRNA CTD PMID:30171875 benzo[a]pyrene increases expression ISO RGD:1353830 6480464 Benzo(a)pyrene results in increased expression of FOXC1 mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases methylation ISO RGD:1353830 6480464 Benzo(a)pyrene results in increased methylation of FOXC1 promoter CTD PMID:27901495 bis(2-chloroethyl) sulfide increases expression ISO RGD:1620902 6480464 Mustard Gas results in increased expression of FOXC1 mRNA CTD PMID:15674844 bisphenol A increases expression ISO RGD:1353830 6480464 bisphenol A results in increased expression of FOXC1 mRNA CTD PMID:16029874 , PMID:28711546 bisphenol A increases expression ISO RGD:1620902 6480464 bisphenol A results in increased expression of FOXC1 mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A affects methylation ISO RGD:1620902 6480464 bisphenol A affects the methylation of FOXC1 promoter CTD PMID:27334623 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FOXC1 mRNA CTD PMID:25181051 more ... bisphenol F increases expression ISO RGD:1620902 6480464 bisphenol F results in increased expression of FOXC1 mRNA CTD PMID:30951980 buta-1,3-diene decreases expression ISO RGD:1620902 6480464 1, 3-butadiene results in decreased expression of FOXC1 mRNA CTD PMID:29038090 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of FOXC1 mRNA CTD PMID:33453195 calcitriol increases expression ISO RGD:1353830 6480464 Calcitriol results in increased expression of FOXC1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1353830 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of FOXC1 mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1353830 6480464 Carbamazepine affects the expression of FOXC1 mRNA CTD PMID:25979313 chlorpyrifos increases expression ISO RGD:1620902 6480464 Chlorpyrifos results in increased expression of FOXC1 mRNA CTD PMID:37019170 cisplatin affects response to substance ISO RGD:1353830 6480464 FOXC1 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin increases expression ISO RGD:1353830 6480464 Cisplatin results in increased expression of FOXC1 mRNA CTD PMID:19561079 clomiphene decreases expression ISO RGD:1353830 6480464 Clomiphene results in decreased expression of FOXC1 mRNA CTD PMID:26865669 cobalt dichloride decreases expression ISO RGD:1353830 6480464 cobaltous chloride results in decreased expression of FOXC1 mRNA CTD PMID:19376846 copper(II) sulfate increases expression ISO RGD:1353830 6480464 Copper Sulfate results in increased expression of FOXC1 mRNA CTD PMID:19549813 coumarin increases phosphorylation ISO RGD:1353830 6480464 coumarin results in increased phosphorylation of FOXC1 protein CTD PMID:35688186 cyclosporin A increases expression ISO RGD:1620902 6480464 Cyclosporine results in increased expression of FOXC1 mRNA CTD PMID:19770486 cyclosporin A decreases methylation ISO RGD:1353830 6480464 Cyclosporine results in decreased methylation of FOXC1 promoter CTD PMID:27989131 cyclosporin A decreases expression ISO RGD:1353830 6480464 Cyclosporine results in decreased expression of FOXC1 mRNA CTD PMID:27989131 cyclosporin A increases expression ISO RGD:1353830 6480464 Cyclosporine results in increased expression of FOXC1 mRNA CTD PMID:25562108 DDE increases activity ISO RGD:1353830 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of FOXC1 protein CTD PMID:27589886 dexamethasone increases expression ISO RGD:1620902 6480464 Dexamethasone results in increased expression of FOXC1 mRNA CTD PMID:22733784 diethylstilbestrol increases expression ISO RGD:1353830 6480464 Diethylstilbestrol results in increased expression of FOXC1 mRNA CTD PMID:26865669 dorsomorphin multiple interactions ISO RGD:1353830 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1353830 6480464 Doxorubicin results in decreased expression of FOXC1 mRNA CTD PMID:29803840 estrone increases expression ISO RGD:1353830 6480464 Estrone results in increased expression of FOXC1 mRNA CTD PMID:26865669 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of FOXC1 mRNA CTD PMID:30307764 folic acid decreases expression ISO RGD:1353830 6480464 Folic Acid results in decreased expression of FOXC1 mRNA CTD PMID:21867686 fulvestrant decreases expression ISO RGD:1353830 6480464 fulvestrant results in decreased expression of FOXC1 mRNA CTD PMID:26865669 furan increases expression EXP 6480464 furan results in increased expression of FOXC1 mRNA CTD PMID:27387713 genistein increases expression ISO RGD:1353830 6480464 Genistein results in increased expression of FOXC1 mRNA CTD PMID:26865669 genistein increases expression ISO RGD:1620902 6480464 Genistein results in increased expression of FOXC1 mRNA CTD PMID:32186404 hexestrol increases expression ISO RGD:1353830 6480464 Hexestrol results in increased expression of FOXC1 mRNA CTD PMID:26865669 hydrogen peroxide affects expression ISO RGD:1353830 6480464 Hydrogen Peroxide affects the expression of FOXC1 mRNA CTD PMID:20044591 isoflurane decreases methylation ISO RGD:1620902 6480464 Isoflurane results in decreased methylation of FOXC1 mRNA CTD PMID:35249202 menadione affects expression ISO RGD:1353830 6480464 Vitamin K 3 affects the expression of FOXC1 mRNA CTD PMID:20044591 mercury dibromide increases expression ISO RGD:1353830 6480464 mercuric bromide results in increased expression of FOXC1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1353830 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC1 mRNA CTD PMID:27188386 mestranol increases expression ISO RGD:1353830 6480464 Mestranol results in increased expression of FOXC1 mRNA CTD PMID:26865669 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of FOXC1 mRNA CTD PMID:30047161 methotrexate decreases expression ISO RGD:1353830 6480464 Methotrexate results in decreased expression of FOXC1 mRNA CTD PMID:24449571 methylisothiazolinone increases expression ISO RGD:1353830 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of FOXC1 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1353830 6480464 methylmercuric chloride results in increased expression of FOXC1 mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium increases methylation EXP 6480464 1-Methyl-4-phenylpyridinium results in increased methylation of FOXC1 gene CTD PMID:28801915 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of FOXC1 mRNA CTD PMID:28801915 nickel atom decreases expression ISO RGD:1353830 6480464 Nickel results in decreased expression of FOXC1 mRNA CTD PMID:24768652 , PMID:25583101 p-chloromercuribenzoic acid increases expression ISO RGD:1353830 6480464 p-Chloromercuribenzoic Acid results in increased expression of FOXC1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1353830 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC1 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1353830 6480464 panobinostat results in increased expression of FOXC1 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1353830 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC1 mRNA CTD PMID:27188386 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FOXC1 mRNA CTD PMID:33387578 perfluorononanoic acid increases expression ISO RGD:1353830 6480464 perfluoro-n-nonanoic acid results in increased expression of FOXC1 mRNA CTD PMID:32588087 phenobarbital affects expression ISO RGD:1353830 6480464 Phenobarbital affects the expression of FOXC1 mRNA CTD PMID:19159669 pirinixic acid increases expression ISO RGD:1620902 6480464 pirinixic acid results in increased expression of FOXC1 mRNA CTD PMID:20813756 raloxifene decreases expression ISO RGD:1353830 6480464 Raloxifene Hydrochloride results in decreased expression of FOXC1 mRNA CTD PMID:26865669 SB 431542 multiple interactions ISO RGD:1353830 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sevoflurane decreases methylation ISO RGD:1620902 6480464 Sevoflurane results in decreased methylation of FOXC1 mRNA CTD PMID:35249202 sodium arsenate decreases expression ISO RGD:1620902 6480464 sodium arsenate results in decreased expression of FOXC1 mRNA CTD PMID:30953684 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of FOXC1 mRNA CTD PMID:30047161 tamoxifen affects expression ISO RGD:1353830 6480464 Tamoxifen affects the expression of FOXC1 mRNA CTD PMID:14699072 temozolomide increases expression ISO RGD:1353830 6480464 Temozolomide results in increased expression of FOXC1 mRNA CTD PMID:31758290 testosterone multiple interactions ISO RGD:1353830 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of FOXC1 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1353830 6480464 Testosterone results in increased expression of FOXC1 mRNA CTD PMID:21592394 thimerosal decreases expression ISO RGD:1353830 6480464 Thimerosal results in decreased expression of FOXC1 mRNA CTD PMID:27188386 titanium dioxide decreases expression ISO RGD:1620902 6480464 titanium dioxide results in decreased expression of FOXC1 mRNA CTD PMID:23557971 , PMID:29264374 toluene increases expression EXP 6480464 Toluene results in increased expression of FOXC1 mRNA CTD PMID:22967744 triadimefon decreases expression EXP 6480464 triadimefon results in decreased expression of FOXC1 mRNA CTD PMID:30047161 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of FOXC1 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1353830 6480464 trichostatin A results in increased expression of FOXC1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1353830 6480464 [Decitabine co-treated with trichostatin A] results in increased expression of FOXC1 mRNA more ... CTD PMID:17891453 , PMID:27188386 triclosan decreases expression ISO RGD:1353830 6480464 Triclosan results in decreased expression of FOXC1 mRNA CTD PMID:30510588 urethane increases expression ISO RGD:1353830 6480464 Urethane results in increased expression of FOXC1 mRNA CTD PMID:28818685 valproic acid increases methylation ISO RGD:1353830 6480464 Valproic Acid results in increased methylation of FOXC1 gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of FOXC1 mRNA CTD PMID:34779009 valproic acid multiple interactions ISO RGD:1353830 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1620902 6480464 Valproic Acid analog results in increased expression of FOXC1 mRNA CTD PMID:21427059 valproic acid increases expression ISO RGD:1353830 6480464 Valproic Acid results in increased expression of FOXC1 mRNA CTD PMID:23179753 more ... vorinostat increases expression ISO RGD:1353830 6480464 vorinostat results in increased expression of FOXC1 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:1353830 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC1 mRNA CTD PMID:27188386
